The upgrade in the price target by HC Wainwright & Co. reflects a positive outlook on Nuvation Bio, likely due to the company's strong fundamentals or potential growth prospects. This endorsement from a reputable analyst could lead to increased investor confidence and a potential short-term uptick in NUVB's stock price.